A pre-clinical biotech company aiming to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy in a more efficient and practical manner.
Market
Healthcare & Wellness
Coinvestors
Breakout Ventures,Delos Capital Fund II, LP,Boehringer Ingelheim Venture Fund USA, Inc,Ascension Ventures